You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

ACETIC ACID, GLACIAL; HYDROCORTISONE; NEOMYCIN SULFATE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for acetic acid, glacial; hydrocortisone; neomycin sulfate and what is the scope of freedom to operate?

Acetic acid, glacial; hydrocortisone; neomycin sulfate is the generic ingredient in one branded drug marketed by Bayer Pharms and is included in one NDA. Additional information is available in the individual branded drug profile pages.

Summary for ACETIC ACID, GLACIAL; HYDROCORTISONE; NEOMYCIN SULFATE
US Patents:0
Tradenames:1
Applicants:1
NDAs:1
DailyMed Link:ACETIC ACID, GLACIAL; HYDROCORTISONE; NEOMYCIN SULFATE at DailyMed
Anatomical Therapeutic Chemical (ATC) Classes for ACETIC ACID, GLACIAL; HYDROCORTISONE; NEOMYCIN SULFATE
A01AB Antiinfectives and antiseptics for local oral treatment
A01A STOMATOLOGICAL PREPARATIONS
A01 STOMATOLOGICAL PREPARATIONS
A Alimentary tract and metabolism
A01AC Corticosteroids for local oral treatment
A01A STOMATOLOGICAL PREPARATIONS
A01 STOMATOLOGICAL PREPARATIONS
A Alimentary tract and metabolism
A07AA Antibiotics
A07A INTESTINAL ANTIINFECTIVES
A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS
A Alimentary tract and metabolism
A07EA Corticosteroids acting locally
A07E INTESTINAL ANTIINFLAMMATORY AGENTS
A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS
A Alimentary tract and metabolism
B05CA Antiinfectives
B05C IRRIGATING SOLUTIONS
B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
B Blood and blood forming organs
C05AA Corticosteroids
C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE
C05 VASOPROTECTIVES
C Cardiovascular system
D06AX Other antibiotics for topical use
D06A ANTIBIOTICS FOR TOPICAL USE
D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE
D Dermatologicals
D07AA Corticosteroids, weak (group I)
D07A CORTICOSTEROIDS, PLAIN
D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS
D Dermatologicals
D07XA Corticosteroids, weak, other combinations
D07X CORTICOSTEROIDS, OTHER COMBINATIONS
D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS
D Dermatologicals
G01AD Organic acids
G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS
G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS
G Genito-urinary system and sex hormones
H02AB Glucocorticoids
H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
H02 CORTICOSTEROIDS FOR SYSTEMIC USE
H Systemic hormonal preparations, excluding sex hormones and insulins
H02AB Glucocorticoids
H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
H02 CORTICOSTEROIDS FOR SYSTEMIC USE
H Systemic hormonal preparations, excluding sex hormones and insulins
J01GB Other aminoglycosides
J01G AMINOGLYCOSIDE ANTIBACTERIALS
J01 ANTIBACTERIALS FOR SYSTEMIC USE
J Antiinfectives for systemic use
R02AB Antibiotics
R02A THROAT PREPARATIONS
R02 THROAT PREPARATIONS
R Respiratory system
S01AA Antibiotics
S01A ANTIINFECTIVES
S01 OPHTHALMOLOGICALS
S Sensory organs
S01BA Corticosteroids, plain
S01B ANTIINFLAMMATORY AGENTS
S01 OPHTHALMOLOGICALS
S Sensory organs
S01BA Corticosteroids, plain
S01B ANTIINFLAMMATORY AGENTS
S01 OPHTHALMOLOGICALS
S Sensory organs
S01CB Corticosteroids/antiinfectives/mydriatics in combination
S01C ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION
S01 OPHTHALMOLOGICALS
S Sensory organs
S02AA Antiinfectives
S02A ANTIINFECTIVES
S02 OTOLOGICALS
S Sensory organs
S02AA Antiinfectives
S02A ANTIINFECTIVES
S02 OTOLOGICALS
S Sensory organs
S02BA Corticosteroids
S02B CORTICOSTEROIDS
S02 OTOLOGICALS
S Sensory organs
S03AA Antiinfectives
S03A ANTIINFECTIVES
S03 OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS
S Sensory organs

US Patents and Regulatory Information for ACETIC ACID, GLACIAL; HYDROCORTISONE; NEOMYCIN SULFATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bayer Pharms NEO-CORT-DOME acetic acid, glacial; hydrocortisone; neomycin sulfate SUSPENSION/DROPS;OTIC 050238-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

ACETIC ACID, GLACIAL; HYDROCORTISONE; NEOMYCIN SULFATE Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory of Glacial Acetic Acid

Introduction to Glacial Acetic Acid

Glacial acetic acid, a highly concentrated form of acetic acid, is a versatile chemical with a wide range of applications across various industries. This article delves into the market dynamics, financial trajectory, and key factors influencing the demand for glacial acetic acid, particularly in the context of its use in combination with hydrocortisone and neomycin sulfate.

Market Size and Growth

The global glacial acetic acid market is experiencing significant growth. As of 2023, the market size was valued at USD 8264.4 million, and it is projected to reach USD 8801.6 million in 2024. The market is expected to grow at a Compound Annual Growth Rate (CAGR) of 6.5% from 2024 to 2034, reaching a value of USD 16521.8 million by 2034[3].

Key Drivers of Growth

Industrial Expansion

The consistent growth of the chemical sector, particularly in the Asia Pacific region, is a major driver of the glacial acetic acid market. The acid is essential for the manufacturing of purified terephthalic acid (PTA) used in textiles and packaging, and its demand is fueled by the expansion of these industries[3].

Pharmaceutical and Medical Applications

Glacial acetic acid is used in various medical applications, including ear drops in combination with hydrocortisone and neomycin sulfate. These combinations are used to treat ear infections and relieve symptoms such as redness, itching, and swelling[2].

Sustainability and Environmental Regulations

The potential of glacial acetic acid as a sustainable solvent presents novel opportunities for growth. Companies are investing in research and development to optimize production procedures using environmentally friendly feedstock, reducing the environmental footprint of the industry. Governments are also implementing stringent environmental laws and offering incentives for bio-based acetic production, which is driving the market forward[3].

Impact of COVID-19

The COVID-19 pandemic had a temporary but significant impact on the glacial acetic acid market. The demand plummeted in 2020 due to global industrial operations decline and disruptions in the raw material supply chain. However, as restrictions eased, the demand quickly rebounded and even exceeded pre-pandemic levels due to pent-up requirements and economic recovery[1][3].

Regional Dynamics

Asia Pacific

The Asia Pacific region is projected to hold the largest share in the global glacial acetic acid market. Rapid industrialization, increasing demand from end-user industries, and significant automobile production in countries like China are key factors boosting the growth in this region[5].

North America

North America is also expected to grow at a significant rate, driven by changing consumer lifestyles and rising health concerns. The region offers lucrative opportunities for market growth due to its diverse industrial base and consumer demand[5].

Financial Trajectory

The financial trajectory of the glacial acetic acid market is influenced by several factors:

Supply and Demand Dynamics

The price of glacial acetic acid can fluctuate based on supply and demand dynamics. High demand, particularly from the Asia Pacific region, can lead to price hikes, while high inventory levels and competition among manufacturers can result in price reductions[3].

Feedstock Costs and Production

The cost of manufacturing glacial acetic acid is significantly impacted by changes in natural gas prices and the use of alternative feedstock such as bio-based acetic acid. Companies are exploring novel and environmentally friendly feedstock to reduce costs and environmental impact[3].

Trade Conflicts and Tariffs

Trade conflicts and tariffs can affect import/export costs and disrupt global supply networks. Businesses in the glacial acetic acid sector are likely to mitigate these risks by obtaining long-term supply agreements, diversifying regional operations, and using financial instruments like contracts[3].

Applications in Combination with Hydrocortisone and Neomycin Sulfate

Glacial acetic acid, when combined with hydrocortisone and neomycin sulfate, is used in otic solutions to treat ear infections. These combinations help relieve redness, itching, and swelling associated with ear canal conditions. The demand for these medical applications is steady and growing, particularly driven by the global expansion of the pharmaceutical sector[2].

Key Takeaways

  • The global glacial acetic acid market is projected to grow at a CAGR of 6.5% from 2024 to 2034.
  • The market is driven by industrial expansion, particularly in the Asia Pacific region.
  • Sustainability and environmental regulations are key factors influencing the market.
  • The COVID-19 pandemic had a temporary impact on the market, but demand has since rebounded.
  • Regional dynamics, especially in Asia Pacific and North America, play a crucial role in market growth.
  • Financial trajectory is influenced by supply and demand dynamics, feedstock costs, and trade conflicts.

FAQs

Q: What is the expected market size of glacial acetic acid by 2034? A: The global glacial acetic acid market is expected to reach a value of USD 16521.8 million by 2034[3].

Q: How did the COVID-19 pandemic affect the glacial acetic acid market? A: The pandemic caused a temporary decline in demand due to global industrial operations decline and supply chain disruptions, but demand rebounded and exceeded pre-pandemic levels as restrictions eased[1][3].

Q: What are the primary applications of glacial acetic acid? A: Glacial acetic acid is used in the manufacturing of PTA, as a solvent, and in medical applications such as ear drops in combination with hydrocortisone and neomycin sulfate[2][3].

Q: Which region is expected to dominate the glacial acetic acid market? A: The Asia Pacific region is projected to hold the largest share in the global glacial acetic acid market due to rapid industrialization and increasing demand from end-user industries[5].

Q: How do environmental regulations impact the glacial acetic acid market? A: Environmental regulations and the push for sustainability are driving the market towards the use of bio-based acetic acid and more environmentally friendly production processes[3].

Sources

  1. Mordor Intelligence: Glacial Acetic Acid Market - Growth Trends & Major Manufacturers
  2. Mayo Clinic: Hydrocortisone and acetic acid (otic route)
  3. Future Market Insights: Glacial Acetic Acid Market Size, Growth & Trends by 2034
  4. GovInfo: HIGHLIGHTS OF THIS ISSUE
  5. Zion Market Research: Glacial acetic acid Market Size, Share, Growth, Trends, and Forecast ...

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.